Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
59.00
+0.05 (0.08%)
May 18, 2026, 4:33 PM CET

BME:ROVI Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
97.3997.9827.1925.32124.9599.04
Short-Term Investments
-0.620.830.110.090.1
Cash & Short-Term Investments
97.3998.628.0225.44125.0399.14
Cash Growth
232.32%251.93%10.15%-79.66%26.13%86.22%
Accounts Receivable
164.27163.31114.83124.55160.23129.8
Other Receivables
-12.0412.6115.9121.0627.83
Receivables
164.27175.36127.44140.46181.28157.63
Inventory
274.18287.98329.95337.97311.94245.47
Prepaid Expenses
3.443.192.692.732.031.79
Other Current Assets
-1.591.512.742.792.33
Total Current Assets
539.28566.71489.61509.33623.07506.36
Property, Plant & Equipment
329.26330.74286.62253.65215.54181.78
Long-Term Investments
19.219.1619.520.592.22.07
Goodwill
2.72.7----
Other Intangible Assets
32.4233.1833.9527.7429.1431.51
Long-Term Deferred Tax Assets
3.463.22.262.342.083.85
Long-Term Deferred Charges
---6.166.67.05
Other Long-Term Assets
--0.070.070.070.07
Total Assets
926.32955.69832.02799.88878.7732.68
Accounts Payable
75.7684.7589.93109.89125.8799.4
Accrued Expenses
-30.2333.1928.8331.6724.6
Current Portion of Long-Term Debt
27.7722.2617.848.068.272.98
Current Portion of Leases
-6.365.855.134.463.44
Current Income Taxes Payable
7.374.42.385.26-0.68
Current Unearned Revenue
36.6429.645.2539.51115.3958.12
Other Current Liabilities
-3.582.213.178.231.17
Total Current Liabilities
147.53181.22156.65199.84293.89190.39
Long-Term Debt
86.6783.8880.538.5846.0452.52
Long-Term Leases
-9.3310.2213.6713.414.22
Long-Term Unearned Revenue
5.125.462.752.793.323.79
Long-Term Deferred Tax Liabilities
0.080.160.371.520.680.78
Other Long-Term Liabilities
0.190.19----
Total Liabilities
239.58280.24250.48256.39357.32261.7
Common Stock
3.073.073.073.243.243.36
Additional Paid-In Capital
87.6487.6487.6487.6487.6487.64
Retained Earnings
589.99578.93486.89556.21456.7446.1
Treasury Stock
-6.75-5.17-5.55-107.68-27.56-66.12
Comprehensive Income & Other
-0.04-0.05-0.02-0.02-0.01-0
Total Common Equity
673.91664.42572.03539.39520.01470.98
Minority Interest
12.8311.049.514.111.37-
Shareholders' Equity
686.73675.46581.54543.49521.38470.98
Total Liabilities & Equity
926.32955.69832.02799.88878.7732.68
Total Debt
114.44121.82114.4165.4372.1773.16
Net Cash (Debt)
-17.05-23.22-86.39-39.9952.8725.97
Net Cash Growth
----103.55%-
Net Cash Per Share
-0.33-0.45-1.69-0.750.990.47
Filing Date Shares Outstanding
51.1551.1551.1551.8253.3754.85
Total Common Shares Outstanding
51.1551.1551.1551.8253.3754.85
Working Capital
391.75385.49332.96309.49329.19315.97
Book Value Per Share
13.1812.9911.1810.419.748.59
Tangible Book Value
638.79628.53538.08511.65490.87439.46
Tangible Book Value Per Share
12.4912.2910.529.879.208.01
Land
-81.7974.860.6545.1237.25
Machinery
-445.19404.19372.97303.78275.44
Construction In Progress
-22.0911.018.4740.1728.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.